about
Interferon beta for secondary progressive multiple sclerosisReducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis databaseFunctional analysis of missense variants in the TRESK (KCNK18) K channelCongenital Abnormalities and Multiple SclerosisMale homosexuality: absence of linkage to microsatellite markers at Xq28A genome-wide screen and linkage mapping for a large pedigree with episodic ataxiaHigh reprint orders in medical journals and pharmaceutical industry funding: case-control studyCrossed cerebral lateralization for verbal and visuo-spatial function in a pair of handedness discordant monozygotic twins: MRI and fMRI brain imagingGenome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.PRKCA and multiple sclerosis: association in two independent populations.The inheritance of resistance alleles in multiple sclerosis.Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis.No effect of preterm birth on the risk of multiple sclerosis: a population based study.The Multiple Sclerosis Risk Sharing Scheme Monitoring Study--early results and lessons for the futureInactive or moderately active human promoters are enriched for inter-individual epialleles.The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions.Multiple sclerosis, vitamin D, and HLA-DRB1*15.The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disabilityA dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura.A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolutionSeasonal distribution of psychiatric births in EnglandExome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 geneMolecular basis of Thomsen's disease (autosomal dominant myotonia congenita).Month of birth, vitamin D and risk of immune-mediated disease: a case control studyHexose-6-phosphate dehydrogenase: a new risk gene for multiple sclerosis.Genetic, environmental and stochastic factors in monozygotic twin discordance with a focus on epigenetic differences.Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis.Twin concordance and sibling recurrence rates in multiple sclerosis.MHC transmission: insights into gender bias in MS susceptibility.Association of UV radiation with multiple sclerosis prevalence and sex ratio in FranceMicrochimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis.Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune diseaseRisk alleles for multiple sclerosis in multiplex families.Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis.Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.Vitamin D receptor binding, chromatin states and association with multiple sclerosis.Prognostic factors for multiple sclerosis: the importance of natural history studies.Origins of magic: review of genetic and epigenetic effects
P50
Q24240509-591EF630-F5BD-40E1-B69E-3EDE3C711C29Q24288959-E2F6F495-6B25-4DDF-B98B-5FE3D5A39F8FQ24602232-69EF8FE2-6609-449B-BCF1-9AC010045CFBQ27496682-1285B0ED-C836-4E84-8DEC-C22BC286E297Q28142177-B6F2B0B5-F3AA-42A6-A1E6-8144044DEE36Q28261023-22FDD04B-538B-497A-B123-325F2C7338E0Q28727838-348C0C19-BBE8-43F3-A9DD-8D81816CFDE8Q28754374-4A051518-2204-4F8B-BE52-B543EE99BCF6Q29417047-DA681604-C7BA-4F81-B6CA-94798739BCB2Q33238942-F06E71DC-DF78-4857-B2DA-E6E9AFDE8BA3Q33298407-A1AFA76A-9867-447E-A239-D5A1238D6B3CQ33349615-68D4209E-0A1B-4AB9-90EA-02351BD6BE15Q33357046-2691EAC0-CBB4-4E45-A0BB-014981D311FCQ33397837-65A85DF9-704C-47FD-8B04-04C95708AA8AQ33742167-32ADEC2D-B991-42E5-82B9-37FA04476D53Q33813291-EC5902DB-B678-4911-BA5F-72079381FDDDQ33899907-242DE748-CF21-4FE7-8112-5E55D8CB272CQ33944200-8E3AA1F4-FBC2-4CBC-B286-C8048FCA91A5Q34140189-EEE24C5B-42FC-420B-BC72-DEE8E52C8822Q34153604-D93C8834-CBA2-4994-A5D0-B7439E4CAE1CQ34230382-67490A4D-015D-4ECF-B029-CA41D1A26939Q34284850-D4FDE02A-C1BC-427F-A821-C33227A27C8EQ34327027-99E8E43C-0CD3-4E90-950E-1453743811F7Q34327362-2045AD45-A312-4E3F-B6C2-C2078AB01DA8Q34329046-626AD453-5570-47F7-98DE-4C1C07475499Q34381971-279E2430-B93E-4093-9881-57B6032806B1Q34456223-B38F42D8-1BB0-45D9-B8D5-E0ECA66DEEF5Q34542659-EF7C0C2A-D7AD-453A-A376-6059B248C6C9Q34555282-801B29D5-59E0-4CC6-8464-64610F9EBE5DQ34555392-0D9D9756-70DE-4E14-89ED-567357362064Q34646812-0D2209F3-940E-45E6-92B8-DFBD9D1C2D81Q34733337-D4E1B490-BEB6-4AD2-904B-32B04E84B70BQ34815644-3353707B-C156-4BF1-8341-310E489BB9D6Q34985640-DC904437-7FBC-486C-AEF0-953A6DB6B30AQ35008221-0B54B771-012B-4AE7-A441-7315F2ED7185Q35239032-AB28C388-75AC-47CE-94EE-6C4EF87988CAQ35909839-64A2F74E-E95F-47EF-8550-07B83B79A11BQ36122415-70DEB85D-7BD1-47D0-A6BC-A79E59C148EDQ36260705-55CD95B6-0D47-4BF7-9024-66D52F032ED2Q36294687-232C4BBC-1AD7-4D46-BF9F-855CB42FE58C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
George C. Ebers
@ast
George C. Ebers
@en
George C. Ebers
@es
George C. Ebers
@nl
George C. Ebers
@sl
type
label
George C. Ebers
@ast
George C. Ebers
@en
George C. Ebers
@es
George C. Ebers
@nl
George C. Ebers
@sl
altLabel
George C Ebers
@en
prefLabel
George C. Ebers
@ast
George C. Ebers
@en
George C. Ebers
@es
George C. Ebers
@nl
George C. Ebers
@sl
P106
P1153
15219142200
P21
P31
P4012
P496
0000-0003-4771-4177
P5395
george-c-ebers